Accumulation of marginal zone B cells and accelerated loss of follicular dendritic cells in NF-κB p50-deficient mice

BMC Immunology

Volumn 6, Issue , 2005, Pages

  Ferguson, Andrew R ^a   Corley, Ronald B ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN; CD23 ANTIGEN; CD9 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN M; PROTEIN P50; TRANSCRIPTION FACTOR;

ADOLESCENT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CELL POPULATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DENDRITIC CELL; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LYMPH FOLLICLE; LYMPHOCYTE COUNT; MALE; MOUSE; NONHUMAN; PHENOTYPE; SINUS VENOSUS; SPLEEN; AGING; ANIMAL; CYTOLOGY; DISEASE COURSE; FOLLICULAR DENDRITIC CELL; GENETICS; IMMUNE DEFICIENCY; IMMUNOLOGY; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

AGING; ANIMALS; ANTIGEN-ANTIBODY COMPLEX; B-LYMPHOCYTE SUBSETS; DENDRITIC CELLS, FOLLICULAR; DISEASE PROGRESSION; IMMUNOGLOBULIN M; IMMUNOLOGIC DEFICIENCY SYNDROMES; INJECTIONS, INTRAVENOUS; LYMPHOCYTE COUNT; MICE; MICE, KNOCKOUT; NF-KAPPA B P50 SUBUNIT; SPLEEN;

EID: 26444513287     PISSN: 14712172     EISSN: 14712172     Source Type: Journal    
DOI: 10.1186/1471-2172-6-8     Document Type: Article

References (48)

1. Henry C, Jerne NK: Competition of 19S and 7S antigen receptors in the regulation of the primary immune response. J Exp Med 1968, 128:133-152.
2. Dennert G: The mechanism of antibody-induced stimulation and inhibition of the immune response. J Immunol 1971, 106:951-995.
3. Heyman B, Andrighetto G, Wigzell H: Antigen-dependent IgM-mediated enhancement of the sheep erythrocyte response in mice. Evidence for induction of B cells with specificities other than that of the injected antibodies. J Exp Med 1982,155:994-1009.
4. Harte PG, Cooke A, Playfair JHL: Specific monoclonal IgM is a potent adjuvant in murine malaria vaccination. Nature 1983, 302:256-258.
5. Heyman B, Wigzell H: Specific IgM enhances and IgG inhibits the induction of immunological memory in mice. Scand J Immunol 1985, 21:255-266.
6. Basalp A, Cirakoglu B, Bermek E: Enhancement of the immune response to hepatitis B virus vaccine by antigen specific IgM. Immunol Lett 2000, 73:1-6.
7. Youd ME, Ferguson AR, Corley RB: Synergistic roles of IgM and complement in antigen trapping and follicular localization. Eur J Immunol 2002, 32:2328-2337.
8. Heyman B, Pilström L, Shulman MJ: Complement activation is required for IgM-mediated enhancement of the antibody response. J Exp Med 1988, 167:1999-2004.
9. Applequist SE, Dahlstrom J, Jiang N, Molina H, Heyman B: Antibody production in mice deficient for complement receptors 1 and 2 can be induced by IgG/Ag and IgE/Ag, but not IgM/Ag complexes. J Immunol 2000, 165:2398-2403.
10. Boes M, Esau C, Fischer MB, Schmidt T, Carroll M, Chen J: Enhanced B-1 cell development, but impaired IgG antibody responses in mice deficient in s ecreted IgM. J Immunol 1998, 160:4776-4787.
11. Boes M, Prodeus AP, Schmidt T, Carroll MC, Chen J: A critical role of natural immunoglobulin M in immediate defense against systemic bacterial infection. J Exp Med 1998, 188:2381-2386.
12. Ehrenstein MR, O'Keefe TL, Davies SL, Neuberger MS: Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response. Proc Natl Acad Sci USA 1998, 95:10089-10093.
13. Baumgarth N, Herman OC, Jager GC, Brown LE, Herzenberg LA, Chen J: B-1 and B-2 cell-derived immunoglobulin M antibodies are nonredundant components of the protective response to influenza virus infection. J Exp Med 2000, 192:271-280.
14. Ochsenbein AF, Fehr T, Lutz C, Suter M, Brombacher F, Hengartner H, Zinkernagel RM: Control of early viral and bacterial distribution and disease by natural antibodies. Science 1999, 286:2156-2159.
15. Ferguson AR, Youd ME, Corley RB: Marginal zone B cells transport and deposit IgM-containing immune complexes onto follicular dendritic cells. Int Immunol 2004, 16:1411-1422.
16. Sha WC, Liou HC, Tuomanen EI, Baltimore D: Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 1995, 80:321-330.
17. Cariappa A, Liou HC, Horwitz BH, Pillai S: Nuclear factor κB is required for the development of marginal zone B lymphocytes. J Exp Med 2000, 192:1175-1182.
18. Oliver AM, Martin F, Gartland GL, Carter RH, Kearney JF: Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 1997, 27:2366-2374.
19. Takahashi K, Kozono Y, Waldschmidt TJ, Berthiaume D, Quigg RJ, Baron A, Holers VM: Mouse complement receptors type 1 (CR1;CD35) and type 2 (CR2;CD21): expression on normal B cell subpopulations and decreased levels during the development of autoimmunity in MRL/lpr mice. J Immunol 1997, 159:1557-1569.
20. Amano M, Baumgarth N, Dick MD, Brossay L, Kronenberg M, Herzenberg LA, Strober S: CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: beta 2-microglobulin-dependent and independent forms. J Immunol 1998, 161:1710-1717.
21. Makowska A, Faizunnessa NN, Anderson P, Midtvedt T, Cardell S: CD1 high B cells: a population of mixed origin. Eur J Immunol 1999, 29:3285-3294.
22. Allman D, Lindsley RC, DeMuth W, Rudd K, Shinton SA, Hardy RR: Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J Immunol 2001, 167:6834-6840.
23. Kraal G, Janse M: Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody. Immunology 1986, 58:665-669.
24. Won WJ, Kearney JF: CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J Immunol 2002, 168:5605-5611.
25. Kumararatne DS, MacLennan IC: Cells of the marginal zone of the spleen are lymphocytes derived from recirculating precursors. Eur J Immunol 1981, 11:865-869.
26. Wang SL, Kutsche M, DiSciullo G, Schachner M, Bogen SA: Selective malformation of the splenic white pulp border in L1-deficient mice. J Immunol 2000, 165:2465-2473.
27. Aydar Y, Balogh P, Tew JG, Szakal AK: Follicular dendritic cells in aging, a "bottle-neck" in the humoral immune response. Ageing Res Rev 2004, 3:15-29.
28. Kosco-Vilbois MH, Zentgraf H, Gerdes J, Bonnefoy JY: To 'B' or not to 'B' a germinal center? Immunol Today 1997, 18:225-230.
29. Taylor PR, Pickering MC, Kosco-Vilbois MH, Walport MJ, Botto M, Gordon S, Martinez-Pomares L: The follicular dendritic cell restricted epitope, FDC-M2, is complement C4; localization of immune complexes in mouse tissues. Eur J Immunol 2002, 32:1888-1896.
30. Liu YJ, Oldfield S, MacLennan IC: Memory B cells in T cell-dependent antibody responses colonize the splenic marginal zones. Eur J Immunol 1988, 18:355-362.
31. Surh CD, Sprent J: Regulation of naive and memory T-cell homeostasis. Microbes Infect 2002, 4:51-56.
32. Cabatingan MS, Schmidt MR, Sen R, Woodland RT: Naive B lymphocytes undergo homeostatic proliferation in response to B cell deficit. J Immunol 2002, 169:6795-6805.
33. Gold MR, Ingham RJ, McLeod SJ, Christian SL, Scheid MP, Duronio V, Santos L, Matsuuchi L: Targets of B-cell antigen receptor signaling: the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase-3 signaling pathway and the Rap1 GTPase. Immunol Rev 2000, 176:47-68.
34. Gugasyan R, Grumont R, Grossmann M, Nakamura Y, Pohl T, Nesic D, Gerondakis S: Rel/NF-κB transcription factors: key mediators of B-cell activation. Immunol Rev 2000, 176:134-410.
35. Aggarwal BB: Signalling pathways of the TNF superfamily: a double-edged sword. Nat Rev Immunol 2003, 3:745-756.
36. Cariappa A, Tang M, Parng C, Nebelitskiy E, Carroll M, Georgopoulos K, Pillai S: The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 2001, 14:603-615.
37. Casola S, Otipoby KL, Alimzhanov M, Humme S, Uyttersprot N, Kutok JL, Carroll MC, Rajewsky K: B cell receptor signal strength determines B cell fate. Nat Immunol 2004, 5:317-327.
38. Mackay F, Woodcock SA, Lawton P, Ambrose C, Baetscher M, Schneider P, Tschopp J, Browning JL: Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999, 190:1697-1710.
39. Lu TT, Cyster JG: Integrin-mediated long-term B cell retention in the splenic marginal zone. Science 2002, 297:409-412.
40. Hao Z, Rajewsky K: Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow. J Exp Med 2001, 194:1151-1164.
41. Guinamard R, Okigaki M, Schlessinger J, Ravetch JV: Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat Immunol 2000, 1:31-36.
42. Karlsson MC, Guinamard R, Bolland S, Sankala M, Steinman RM, Ravetch JV: Macrophages control the retention and trafficking of B lymphocytes in the splenic marginal zone. J Exp Med 2003, 198:333-340.
43. Cinamon G, Matloubian M, Lesneski MJ, Xu Y, Low C, Lu T, Proia RL, Cyster JG: Sphingosine 1-phosphate receptor 1 promotes B cell localization in the splenic marginal zone. Nat Immunol 2004, 5:713-20.
44. Cyster JG, Ansel KM, Reif K, Ekland EH, Hyman PL, Tang HL, Luther SA, Ngo VN: Follicular stromal cells and lymphocyte homing to follicles. Immunol Rev 2000, 176:181-193.
45. Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC: Sites of specific B cell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol 1991, 21:2951-2962.
46. Martin F, Oliver AM, Kearney JF: Marginal zone and B1 B cells unite in the early response against T-independent blood-borne particulate antigens. Immunity 2001, 14:617-629.
47. Song H, Cerny J: Functional heterogeneity of marginal zone B cells revealed by their ability to generate both early antibody-forming cells and germinal centers with hypermutation and memory in response to a T-dependent antigen. J Exp Med 2003, 198:1923-1935.
48. Martin F, Kearney JF: Marginal-zone B cells. Nat Rev Immunol 2002, 2:323-335.